Cargando…
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
The ability to utilize preclinical models to predict the clinical toxicity of chimeric antigen receptor (CAR) T cells in solid tumors is tenuous, thereby necessitating the development and evaluation of gated systems. Here we found that murine GD2 CAR-T cells, specific for the tumor-associated antige...
Autores principales: | Moghimi, Babak, Muthugounder, Sakunthala, Jambon, Samy, Tibbetts, Rachelle, Hung, Long, Bassiri, Hamid, Hogarty, Michael D., Barrett, David M., Shimada, Hiroyuki, Asgharzadeh, Shahab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820416/ https://www.ncbi.nlm.nih.gov/pubmed/33479234 http://dx.doi.org/10.1038/s41467-020-20785-x |
Ejemplares similares
-
Engineering Axl specific CAR and SynNotch receptor for cancer therapy
por: Cho, Jang Hwan, et al.
Publicado: (2018) -
Author Correction: Engineering Axl specific CAR and SynNotch receptor for cancer therapy
por: Cho, Jang Hwan, et al.
Publicado: (2020) -
Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting
por: Ruffo, Elisa, et al.
Publicado: (2023) -
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells
por: Luo, Hong, et al.
Publicado: (2019) -
A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
por: A, Ruhan, et al.
Publicado: (2023)